Cargando…

Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology

INTRODUCTION: The purpose of this study was to determine the objective characteristics of orthopaedic musculoskeletal oncology fellowship directors (FDs) by concentrating on the demographics, academic background, institutional history, research experience, and professional affiliations of these lead...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, M. Lane, Elahi, Muhammad Ali, Doan, Matthew K., Pollock, Jordan R., Makovicka, Justin L., Hassebrock, Jeffrey D., Brinkman, Joseph C., Patel, Karan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191358/
https://www.ncbi.nlm.nih.gov/pubmed/35696309
http://dx.doi.org/10.5435/JAAOSGlobal-D-22-00039
_version_ 1784725994579427328
author Moore, M. Lane
Elahi, Muhammad Ali
Doan, Matthew K.
Pollock, Jordan R.
Makovicka, Justin L.
Hassebrock, Jeffrey D.
Brinkman, Joseph C.
Patel, Karan A.
author_facet Moore, M. Lane
Elahi, Muhammad Ali
Doan, Matthew K.
Pollock, Jordan R.
Makovicka, Justin L.
Hassebrock, Jeffrey D.
Brinkman, Joseph C.
Patel, Karan A.
author_sort Moore, M. Lane
collection PubMed
description INTRODUCTION: The purpose of this study was to determine the objective characteristics of orthopaedic musculoskeletal oncology fellowship directors (FDs) by concentrating on the demographics, academic background, institutional history, research experience, and professional affiliations of these leaders. METHODS: Data were collected for each FD through institutional biographies or publicly available curriculum vitae. The data collected for each FD included demographic, professional, and research information. RESULTS: Of the 19 FDs, 15 (78.9%) were male, and 4 (21.1%) were female. The mean age for all FDs was 49.2 ± 9.1 years. Most FDs were White (n = 16; 84.2%). The mean Scopus H-index, total number of citations, and total number of publications among all 19 FDs were 21.6 ± 13.8, 2,290.6 ± 2,709.0, and 84.0 ± 54.7, respectively. The mean number of years serving in the FD role was 7.1 ± 9.1 years, and the mean number of years that the FD was employed at his/her current institution was 11.1 ± 8.1 years. CONCLUSION: This study shows that orthopaedic musculoskeletal oncology FDs were mainly White (84.2%), male (78.9%), and in their late 40s; have filled their role as FD for an average of 7.1 years; and are very productive in research.
format Online
Article
Text
id pubmed-9191358
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-91913582022-06-13 Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology Moore, M. Lane Elahi, Muhammad Ali Doan, Matthew K. Pollock, Jordan R. Makovicka, Justin L. Hassebrock, Jeffrey D. Brinkman, Joseph C. Patel, Karan A. J Am Acad Orthop Surg Glob Res Rev Research Article INTRODUCTION: The purpose of this study was to determine the objective characteristics of orthopaedic musculoskeletal oncology fellowship directors (FDs) by concentrating on the demographics, academic background, institutional history, research experience, and professional affiliations of these leaders. METHODS: Data were collected for each FD through institutional biographies or publicly available curriculum vitae. The data collected for each FD included demographic, professional, and research information. RESULTS: Of the 19 FDs, 15 (78.9%) were male, and 4 (21.1%) were female. The mean age for all FDs was 49.2 ± 9.1 years. Most FDs were White (n = 16; 84.2%). The mean Scopus H-index, total number of citations, and total number of publications among all 19 FDs were 21.6 ± 13.8, 2,290.6 ± 2,709.0, and 84.0 ± 54.7, respectively. The mean number of years serving in the FD role was 7.1 ± 9.1 years, and the mean number of years that the FD was employed at his/her current institution was 11.1 ± 8.1 years. CONCLUSION: This study shows that orthopaedic musculoskeletal oncology FDs were mainly White (84.2%), male (78.9%), and in their late 40s; have filled their role as FD for an average of 7.1 years; and are very productive in research. Wolters Kluwer 2022-06-10 /pmc/articles/PMC9191358/ /pubmed/35696309 http://dx.doi.org/10.5435/JAAOSGlobal-D-22-00039 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Orthopaedic Surgeons. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Moore, M. Lane
Elahi, Muhammad Ali
Doan, Matthew K.
Pollock, Jordan R.
Makovicka, Justin L.
Hassebrock, Jeffrey D.
Brinkman, Joseph C.
Patel, Karan A.
Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology
title Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology
title_full Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology
title_fullStr Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology
title_full_unstemmed Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology
title_short Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology
title_sort investigation of fellowship leadership in orthopaedic musculoskeletal oncology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191358/
https://www.ncbi.nlm.nih.gov/pubmed/35696309
http://dx.doi.org/10.5435/JAAOSGlobal-D-22-00039
work_keys_str_mv AT mooremlane investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology
AT elahimuhammadali investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology
AT doanmatthewk investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology
AT pollockjordanr investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology
AT makovickajustinl investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology
AT hassebrockjeffreyd investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology
AT brinkmanjosephc investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology
AT patelkarana investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology